{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:04:41Z","timestamp":1761897881266,"version":"3.37.3"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HA22C0044","HA22C0098"],"award-info":[{"award-number":["HA22C0044","HA22C0098"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The importance of clinical staging in breast cancer has increased owing to the wide use of neoadjuvant systemic therapy (NST). This study aimed to investigate the current practice patterns regarding clinical nodal staging in breast cancer in real-world settings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>A web-based survey was administered to board-certified oncologists in Korea, including breast surgical, medical, and radiation oncologists, from January to April 2022. The survey included 19 general questions and 4 case-based questions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 122 oncologists (45 radiation, 44 surgical, and 33 medical oncologists) completed the survey. Among them, 108 (88%) responded that clinical staging before NST was primarily performed by breast surgeons. All the respondents referred to imaging studies during nodal staging. Overall, 64 (52.5%) responders determined the stage strictly based on the radiology reports, whereas 58 (47.5%) made their own decision while noting radiology reports. Of those who made their own decisions, 88% referred to the number or size of the suspicious node. Of the 75 respondents involved in prescribing regimens for neoadjuvant chemotherapy, 58 (77.3%) responded that the reimbursement regulations in the selection of NST regimens affected nodal staging in clinical practice. In the case-based questions, high variability was observed among the clinicians in the same cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Diverse assessments by specialists owing to the lack of a clear, harmonized staging system for the clinical nodal staging of breast cancer can lead to diverse practice patterns. Thus, practical, harmonized, and objective methods for clinical nodal staging and for the outcomes of post-NST response are warranted for appropriate treatment decisions and accurate outcome evaluation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyad156","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T13:43:52Z","timestamp":1686318232000},"page":"e1142-e1151","source":"Crossref","is-referenced-by-count":2,"title":["A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer"],"prefix":"10.1093","volume":"28","author":[{"given":"Han-Byoel","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Surgery, Seoul National University College of Medicine , Seoul , Republic of Korea"},{"name":"Biomedical Research Institute, Seoul National University Hospital , Seoul , Republic of Korea"},{"name":"Cancer Research Institute, Seoul National University , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2390-3240","authenticated-orcid":false,"given":"Kyung-Hun","family":"Lee","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Seoul National University , Seoul , Republic of Korea"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul , Republic of Korea"},{"name":"Department of Internal Medicine, Seoul National University Hospital , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Hyun","family":"Song","sequence":"additional","affiliation":[{"name":"Seoul National University College of Medicine , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyubo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ewha Womans University College of Medicine , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Kyu","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Seoul National University College of Medicine , Seoul , Republic of Korea"},{"name":"Biomedical Research Institute, Seoul National University Hospital , Seoul , Republic of Korea"},{"name":"Cancer Research Institute, Seoul National University , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong-Gon","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Surgery, Seoul National University College of Medicine , Seoul , Republic of Korea"},{"name":"Biomedical Research Institute, Seoul National University Hospital , Seoul , Republic of Korea"},{"name":"Cancer Research Institute, Seoul National University , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonshik","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Surgery, Seoul National University College of Medicine , Seoul , Republic of Korea"},{"name":"Biomedical Research Institute, Seoul National University Hospital , Seoul , Republic of Korea"},{"name":"Cancer Research Institute, Seoul National University , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul , Republic of Korea"},{"name":"Department of Internal Medicine, Seoul National University Hospital , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seock-Ah","family":"Im","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Seoul National University , Seoul , Republic of Korea"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul , Republic of Korea"},{"name":"Department of Internal Medicine, Seoul National University Hospital , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bum-Sup","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Seoul National University College of Medicine , Seoul , Republic of Korea"},{"name":"Department of Radiation Oncology, Seoul National University Hospital , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Bae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonghan","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Breast, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital , Seoul National University College of Medicine, Seongnam , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Hee","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hwan","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Seoul National University College of Medicine , Seoul , Republic of Korea"},{"name":"Department of Radiation Oncology, Seoul National University Hospital , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-5522","authenticated-orcid":false,"given":"Ji Hyun","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Seoul National University College of Medicine , Seoul , Republic of Korea"},{"name":"Department of Radiation Oncology, Seoul National University Hospital , Seoul , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"issue":"5","key":"2023122612581059800_CIT0001","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","article-title":"Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols b-18 and b-27","volume":"26","author":"Rastogi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"2023122612581059800_CIT0002","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1245\/s10434-020-09480-9","article-title":"The landmark series: neoadjuvant chemotherapy for triple-negative and her2-positive breast cancer","volume":"28","author":"Leon-Ferre","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"2023122612581059800_CIT0003","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 4.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"2023122612581059800_CIT0004","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"2023122612581059800_CIT0005","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"2023122612581059800_CIT0006","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9935","key":"2023122612581059800_CIT0007","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"","year":"2014","journal-title":"Lancet"},{"issue":"9165","key":"2023122612581059800_CIT0008","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","article-title":"Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial","volume":"353","author":"Overgaard","year":"1999","journal-title":"Lancet"},{"issue":"19","key":"2023122612581059800_CIT0009","first-page":"1878","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"2023122612581059800_CIT0010","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"issue":"12","key":"2023122612581059800_CIT0011","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/bjs.10986","article-title":"Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer","volume":"105","author":"Tee","year":"2018","journal-title":"Br J Surg"},{"issue":"51","key":"2023122612581059800_CIT0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jncimonographs\/lgv003","article-title":"Radiotherapy issues after neoadjuvant chemotherapy","volume":"2015","author":"Mak","year":"2015","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"20","key":"2023122612581059800_CIT0013","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1200\/JCO.19.02576","article-title":"Locoregional management after neoadjuvant chemotherapy","volume":"38","author":"Morrow","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"2023122612581059800_CIT0014","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","volume":"3","author":"Pilewskie","year":"2017","journal-title":"JAMA Oncol"},{"key":"2023122612581059800_CIT0015","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"issue":"3","key":"2023122612581059800_CIT0016","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/radiol.2020192534","article-title":"Axillary nodal evaluation in breast cancer: state of the art","volume":"295","author":"Chang","year":"2020","journal-title":"Radiology"},{"issue":"2","key":"2023122612581059800_CIT0017","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1634\/theoncologist.2019-0427","article-title":"Lymph node imaging in patients with primary breast cancer: concurrent diagnostic tools","volume":"25","author":"Marino","year":"2020","journal-title":"Oncologist"},{"issue":"3","key":"2023122612581059800_CIT0018","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4048\/jbc.2013.16.3.315","article-title":"The comparative study of ultrasonography, contrast-enhanced MRI, and (18)F-FDG PET\/CT for detecting axillary lymph node metastasis in t1 breast cancer","volume":"16","author":"Hwang","year":"2013","journal-title":"J Breast Cancer"},{"issue":"2","key":"2023122612581059800_CIT0019","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1148\/radiol.2412050693","article-title":"Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus USPIO-enhanced MR imaging","volume":"241","author":"Memarsadeghi","year":"2006","journal-title":"Radiology"},{"issue":"5","key":"2023122612581059800_CIT0020","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French Prospective Multicentric Study","volume":"27","author":"Classe","year":"2009","journal-title":"J Clin Oncol"},{"issue":"26","key":"2023122612581059800_CIT0021","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1056\/NEJMc2006684","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Cetin","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"2023122612581059800_CIT0022","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S1470-2045(22)00482-X","article-title":"De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study","volume":"23","author":"de Wild","year":"2022","journal-title":"Lancet Oncol"},{"issue":"2","key":"2023122612581059800_CIT0023","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clbc.2021.06.003","article-title":"Regional nodal irradiation for clinically node-positive breast cancer patients with pathologic negative nodes after neoadjuvant chemotherapy","volume":"22","author":"Schlafstein","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"2023122612581059800_CIT0024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.radonc.2021.06.032","article-title":"Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy: a prelude to NSABP b-51","volume":"162","author":"Haque","year":"2021","journal-title":"Radiother Oncol"},{"issue":"5","key":"2023122612581059800_CIT0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/bjs.11963","article-title":"Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status","volume":"108","author":"Zetterlund","year":"2021","journal-title":"Br J Surg"},{"key":"2023122612581059800_CIT0026","first-page":"TPS600","article-title":"NRG oncology\/NSABP b-51\/RTOG 1304: phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (MX) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAX) nodes who are YPN0 after neoadjuvant chemotherapy (NC)","volume-title":"J Clin Oncol","author":"Mamounas","year":"2019"},{"key":"2023122612581059800_CIT0027"},{"issue":"14","key":"2023122612581059800_CIT0028","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"2023122612581059800_CIT0029","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","article-title":"Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy\u2014a rare event","volume":"7","author":"Barrio","year":"2021","journal-title":"JAMA Oncol"},{"issue":"3","key":"2023122612581059800_CIT0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: The SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"year":"2021","author":"Lee","key":"2023122612581059800_CIT0031"},{"year":"2021","author":"Toralf Reimer","key":"2023122612581059800_CIT0032"},{"issue":"6","key":"2023122612581059800_CIT0033","doi-asserted-by":"crossref","first-page":"e210891","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg."},{"issue":"4","key":"2023122612581059800_CIT0034","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (alliance) prospective multicenter clinical trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/28\/12\/e1142\/54874934\/oyad156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/28\/12\/e1142\/54874934\/oyad156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T12:58:36Z","timestamp":1703595516000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/28\/12\/e1142\/7190550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6,5]]},"published-print":{"date-parts":[[2023,12,11]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyad156","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"type":"print","value":"1083-7159"},{"type":"electronic","value":"1549-490X"}],"subject":[],"published-other":{"date-parts":[[2023,12,1]]},"published":{"date-parts":[[2023,6,5]]}}}